Drug

Mirvetuximab Soravtansine

33 flagged reaction(s) · 950 total co-reports · max PRR 41.5

Important: Reactions below are the flagged terms from this drug’s FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate disproportionality in spontaneous reporting, not causation. Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.

	Reaction	Co-reports (a)	PRR	ROR	Signal
1	Pneumonitis	88	41.5	43.7	signal
2	Ovarian Cancer	24	33.0	33.5	signal
3	Cataract	85	18.2	19.2	signal
4	Intestinal Perforation	15	17.0	17.1	signal
5	Small Intestinal Obstruction	15	15.5	15.7	signal
6	Neuropathy Peripheral	114	15.3	16.4	signal
7	Dry Eye	55	14.4	14.9	signal
8	Vision Blurred	114	10.6	11.3	signal
9	Eye Disorder	27	10.5	10.6	signal
10	Product Preparation Error	17	10.4	10.5	signal
11	Photophobia	15	10.2	10.3	signal
12	Disease Progression	94	10.1	10.7	signal
13	Infusion Related Reaction	43	8.3	8.5	signal
14	Interstitial Lung Disease	31	8.2	8.3	signal
15	Blindness	25	7.8	7.9	signal
16	Retinal Detachment	5	6.9	6.9	signal
17	Neoplasm	6	6.6	6.6	signal
18	Metastases To Lung	6	6.6	6.6	signal
19	Haemorrhage Intracranial	7	5.9	5.9	signal
20	Intestinal Obstruction	17	5.8	5.8	signal
21	Visual Acuity Reduced	15	5.7	5.7	signal
22	Visual Impairment	53	5.5	5.6	signal
23	Polyneuropathy	5	5.3	5.4	signal
24	Hospice Care	4	5.2	5.2	signal
25	Neurotoxicity	7	5.1	5.1	signal
26	Metastases To Liver	6	4.3	4.4	signal
27	Uveitis	4	3.8	3.8	signal
28	Eye Irritation	15	3.4	3.4	signal
29	Injection Site Extravasation	3	3.1	3.1	no signal
30	Intraocular Pressure Increased	3	3.0	3.0	no signal
31	Product Storage Error	20	2.9	3.0	signal
32	Neoplasm Progression	8	2.9	2.9	signal
33	Myelosuppression	4	1.5	1.5	no signal